Stocks LIF Financial statements
Financial statementsLife360, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Life360, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 80.7 | 113 | 228 | 305 | 371 | 489 |
| Cost of revenue | 15.4 | 22.8 | 79.7 | 81.9 | 92.3 | 109 |
| Gross profit | 65.3 | 89.9 | 149 | 223 | 279 | 381 |
| Research and development | 39.6 | 51 | 102 | 101 | 113 | 128 |
| Selling and marketing | 30.2 | 47.5 | 92.4 | 99.1 | 113 | 155 |
| General and administrative | 12.1 | 23.7 | 48.1 | 52.6 | 60.7 | 78.6 |
| Operating income | -16.7 | -32.3 | -94.4 | -30 | -7.98 | 18.8 |
| Other non-operating income | 0.32 | -1.42 | 3.09 | 2.43 | 3.35 | 13.8 |
| Pre-tax income | -16.3 | -33.7 | -91.3 | -27.6 | -4.63 | 32.7 |
| Income tax | 0 | -0.13 | 0.31 | 0.62 | -0.07 | -118 |
| Net income | -16.3 | -33.6 | -91.6 | -28.2 | -4.56 | 151 |
| EBITDA | -16 | -31.4 | -85.2 | -20.8 | 1.8 | 32.2 |
| EPS, basic | -0.33 | -0.65 | -1.47 | -0.42 | -0.06 | 1.95 |
| EPS, diluted | -0.33 | -0.65 | -1.50 | -0.42 | -0.06 | 1.77 |
| Shares, basic (weighted) | 49.3 | 51.7 | 62.2 | 66.7 | 72.1 | 77.3 |
| Shares, diluted (weighted) | 49.3 | 51.7 | 62.8 | 66.7 | 72.1 | 85.2 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 56.4 | 231 | 75.4 | 69 | 159 | 494 |
| Receivables | 11.8 | 33.1 | 42.2 | 58 | 80.7 | |
| Inventory | 2.01 | 10.8 | 4.1 | 8.06 | 9.87 | |
| Other current assets | 10.6 | 8.55 | 15.2 | 14.6 | 20.1 | |
| Total current assets | 257 | 143 | 131 | 241 | 606 | |
| Property, plant and equipment | 0.58 | 0.39 | 0.73 | 1.78 | 3.02 | |
| Lease right-of-use assets | 1.63 | 0.8 | 1.01 | 0.68 | 0.34 | |
| Goodwill | 31.1 | 134 | 134 | 134 | 135 | |
| Intangible assets | 7.99 | 52.7 | 45.4 | 40.6 | 38.3 | |
| Long-term investments | 19.8 | |||||
| Other non-current assets | 0.37 | 0.14 | 0.02 | |||
| Total assets | 302 | 340 | 322 | 442 | 960 | |
| Accounts payable | 3.25 | 13.8 | 5.9 | 5.46 | 8.41 | |
| Accrued liabilities | 1.32 | 3.9 | 3.35 | 3.83 | 7.12 | |
| Deferred revenue | 13.9 | 30.1 | 33.9 | 39.9 | 46.4 | |
| Total current liabilities | 41.4 | 87.6 | 70.8 | 77.3 | 96.8 | |
| Lease liabilities | 0.29 | 0 | 0.72 | 0.36 | 0 | |
| Other non-current liabilities | 1.21 | 0.58 | 0.72 | 0.36 | 0 | |
| Total liabilities | 52.3 | 95.1 | 74.7 | 83 | 412 | |
| Total debt | 7.57 | 4.51 | ||||
| Paid-in capital | 416 | 502 | 532 | 648 | 687 | |
| Retained earnings | -165 | -257 | -285 | -290 | -139 | |
| Treasury stock | 0 | |||||
| Other comprehensive income | 0 | -0.01 | 0.01 | 0.04 | 0.05 | |
| Shareholders' equity | 64.2 | 250 | 245 | 247 | 359 | 548 |
| Total equity | 64.2 | 250 | 245 | 247 | 359 | 548 |
| Total liabilities and equity | 302 | 340 | 322 | 442 | 960 | |
| Shares outstanding | 60.2 | 65.2 | 68.2 | 75.4 | 79.4 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -16.3 | -33.6 | -91.6 | -28.2 | -4.56 | 151 |
| Depreciation and amortization | 0.66 | 0.88 | 9.2 | 9.14 | 9.78 | 13.3 |
| Stock-based compensation | 8.09 | 11.8 | 34.7 | 38.5 | 42.3 | 55.5 |
| Deferred income tax | 0 | 0 | -118 | |||
| Change in receivables | -1.15 | -2.69 | 6.47 | -9.06 | -16.1 | -23.5 |
| Change in inventory | 0 | -0.86 | -0.5 | 5.81 | -3.96 | -1.81 |
| Change in payables | 1.93 | 0.56 | -12.7 | -7.9 | -0.43 | 3.06 |
| Cash from operations | -7.25 | -12.2 | -57.1 | 7.52 | 32.6 | 88.6 |
| Capital expenditures | -0.65 | -0.08 | 0 | -0.51 | -1.19 | -1.79 |
| Acquisitions | 0 | -2.98 | -111 | 0 | 0 | -2.83 |
| Cash from investing | -0.65 | -7.06 | -112 | -2.22 | -10.1 | -35.3 |
| Debt issued | 3.12 | 0 | 0 | |||
| Stock issued | 0 | 193 | 32.2 | 0 | ||
| Cash from financing | 0.45 | 194 | 27.7 | -25 | 67.3 | 282 |
| Net change in cash | -7.46 | 175 | -141 | -19.7 | 89.7 | 335 |
| Free cash flow | -7.9 | -12.2 | -57.1 | 7.02 | 31.4 | 86.8 |
| Interest paid | 0 | 0.02 | 0.51 | 0.64 | 0.05 | 0 |
| Income taxes paid | 0 | 0.03 | 0 | 0.7 | 2.38 | -0.89 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 77.6% | Gross profit / revenue. |
| Operating margin | 1.1% | Operating income / revenue. |
| EBITDA margin | 2.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 2.5% | Pre-tax income / revenue. |
| Net margin | 25.7% | Net income / revenue. |
| FCF margin | 18.0% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 18.2% | Cash from operations / revenue. |
| Effective tax rate | -947.6% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 24.0% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 14.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | 1.5% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 26.6% | Research and development expense / revenue. |
| Stock-based pay / revenue | 12.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.2% | Capital expenditures / revenue. |
| D&A / revenue | 1.6% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 31.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 28.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 43.4% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 36.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 36.8% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 42.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 1,684.0% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | 171.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | 176.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 52.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 30.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 53.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 117.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 41.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 18.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 10.7% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 11.5% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 5.60x | Current assets / current liabilities. |
| Quick ratio | 3.42x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 2.50x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 41.7% | Total liabilities / total assets. |
| Working capital | $492.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 23.9% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $362.3M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.54x | Revenue / average total assets. |
| Fixed asset turnover | 209x | Revenue / average property, plant and equipment. |
| Inventory turnover | 8.72x | Cost of revenue / average inventory. |
| Days inventory | 42 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5.81x | Revenue / average receivables. |
| Days sales outstanding | 63 days | 365 x average receivables / revenue. |
| Days payables | 44 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 60 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 70.1% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 1.0% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.72 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $6.69 | Revenue / diluted weighted shares. |
| FCF per share | $1.21 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.22 | Cash from operations / diluted weighted shares. |
| Book value per share | $7.55 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $4.46 | Tangible book value / shares outstanding. |
| Cash per share | $3.29 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $3.26B | Share price x shares outstanding. |
| Enterprise value | $2.99B | Market cap + total debt - cash - short-term investments. |
| P/E | 22.1x | Market cap / net income. Only when net income is positive. |
| P/S | 5.69x | Market cap / revenue. |
| P/B | 5.31x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 8.99x | Market cap / tangible book value, when positive. |
| P/FCF | 31.6x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 31.2x | Market cap / cash from operations, when positive. |
| EV/Sales | 5.22x | Enterprise value / revenue. |
| EV/EBIT | 459x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 190x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 29.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 3.2% | Free cash flow / market cap. |
| Earnings yield | 4.5% | Net income / market cap (the inverse of P/E). |
What was Life360, Inc.'s revenue in fiscal 2025?
Life360, Inc. reported revenue of $489.5M for fiscal 2025, 31.8% higher than the year before.
Was Life360, Inc. profitable in fiscal 2025?
Yes. Net income was $150.8M, a net margin of 30.8%.
How much free cash flow did Life360, Inc. generate in fiscal 2025?
Cash from operations of $88.6M minus capital expenditures of $1.8M left free cash flow of $86.8M.